As of the latest Form 4 filed Jul 7, 2026.
What Lifestance Health Group Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 65 most recent filings for LFST.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-02 | Palmer Eric P Director | AAward | +17.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Bessler Robert Director | AAward | +17.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Personette Sarah Director | AAward | +17.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | DeLuca Teresa Director | AAward | +17.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Justice Thurman Director | AAward | +35.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Goltermann Lori Director | AAward | +35.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bessler Robert Director | SSale | −447K | $10.13 | $4.53M | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Bessler Robert, Director | SSale | −447K | $10.13 | $4.53M | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Paunovich Vukasin Chief Technology Officer | FTax | −17.5K | $8.61 | $150K | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | TPG GP A, LLC 10% owner | SSale | −28.3M | $8.02 | $227M | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | Bessler Robert Director | SSale | −288K | $8.02 | $2.31M | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | Bessler Robert, Director | SSale | −288K | $8.02 | $2.31M | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | Shuey Eric Director | SSale | −243K | $8.02 | $1.95M | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-12 | BLACK DARREN M. Director | SSale | −5.90M | $8.02 | $47.3M | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | Bessler Robert Director | SSale | −37.5K | $8.55 | $321K | Yes (planned) | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | Bessler Robert, Director | SSale | −37.5K | $8.55 | $321K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Bessler Robert Director | SSale | −31.1K | $7.05 | $219K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Bessler Robert, Director | SSale | −31.1K | $7.05 | $219K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Bessler Robert, Director | SSale | −3.88K | $7.00 | $27.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Bessler Robert, Director | SSale | −3.88K | $7.00 | $27.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-21 | Bessler Robert Director | SSale | −2.55K | $7.01 | $17.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-21 | Bessler Robert, Director | SSale | −2.55K | $7.01 | $17.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | McGroarty Ryan See Remarks | FTax | −24.3K | $6.45 | $156K | No | Form 4 ↗ |
| 2026-03-19 | 2026-03-17 | McGroarty Ryan See Remarks | FTax | −47.6K | $6.89 | $328K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Burdick Kenneth A Director | FTax | −278K | $6.91 | $1.92M | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Burdick Kenneth A, Director | AAward | +707K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Burdick Kenneth A, Director | FTax | −13.2K | $6.91 | $91.2K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Burdick Kenneth A, Director | AAward | +33.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Burdick Kenneth A, Director | FTax | −35.8K | $6.91 | $247K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Bourdon David Chief Executive Officer | FTax | −86.0K | $6.91 | $594K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Bourdon David, Chief Executive Officer | AAward | +206K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Bourdon David, Chief Executive Officer | FTax | −51.5K | $6.91 | $356K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Bourdon David, Chief Executive Officer | AAward | +123K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Bourdon David, Chief Executive Officer | FTax | −10.9K | $6.91 | $75.2K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Miller Lisa K Chief Operating Officer | FTax | −13.4K | $6.91 | $92.9K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Miller Lisa K, Chief Operating Officer | AAward | +26.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Miller Lisa K, Chief Operating Officer | FTax | −14.8K | $6.91 | $102K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Varanakis Ann Chief People Officer | FTax | −25.0K | $6.91 | $173K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Varanakis Ann, Chief People Officer | AAward | +59.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Varanakis Ann, Chief People Officer | FTax | −11.2K | $6.91 | $77.6K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Varanakis Ann, Chief People Officer | AAward | +26.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Varanakis Ann, Chief People Officer | FTax | −8.71K | $6.91 | $60.2K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Pardo Ryan See Remarks | FTax | −38.5K | $6.91 | $266K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Pardo Ryan, See Remarks | AAward | +106K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Pardo Ryan, See Remarks | FTax | −15.8K | $6.91 | $109K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Pardo Ryan, See Remarks | AAward | +40.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Pardo Ryan, See Remarks | FTax | −12.3K | $6.91 | $84.9K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | McGroarty Ryan See Remarks | FTax | −25.6K | $6.91 | $177K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | McGroarty Ryan, See Remarks | AAward | +65.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | McGroarty Ryan, See Remarks | FTax | −50.9K | $6.91 | $352K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | McGroarty Ryan, See Remarks | AAward | +128K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Paunovich Vukasin Chief Technology Officer | FTax | −18.5K | $6.91 | $128K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Paunovich Vukasin, Chief Technology Officer | AAward | +62.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Pardo Ryan See Remarks | FTax | −21.9K | $6.93 | $151K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Bourdon David Chief Executive Officer | FTax | −65.8K | $6.93 | $456K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Burdick Kenneth A Director | FTax | −425K | $7.11 | $3.02M | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Miller Lisa K See Remarks | FTax | −21.6K | $6.93 | $150K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Varanakis Ann Chief People Officer | FTax | −21.6K | $6.93 | $149K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Eken Stephanie Carin Chief Medical Officer | AAward | +115K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Pardo Ryan See Remarks | AAward | +129K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Bourdon David Chief Executive Officer | AAward | +396K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Paunovich Vukasin Chief Technology Officer | AAward | +86.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Miller Lisa K See Remarks | AAward | +108K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Varanakis Ann Chief People Officer | AAward | +86.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | McGroarty Ryan See Remarks | AAward | +180K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also LFST’s full analysis or the market-wide insider trading feed. The tabs above jump to LFST’s other SEC data.
Source: SEC Form 4 filings for LFST, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.